Cardiol Therapeutics Inc. (OTCMKTS:CRTPF – Get Free Report)’s share price traded down 4.3% during trading on Friday . The company traded as low as $1.11 and last traded at $1.12. 88,090 shares traded hands during mid-day trading, an increase of 31% from the average session volume of 67,097 shares. The stock had previously closed at $1.17.
Cardiol Therapeutics Price Performance
The company has a 50-day simple moving average of $1.24 and a two-hundred day simple moving average of $1.58.
About Cardiol Therapeutics
Cardiol Therapeutics Inc is a clinical-stage biotechnology company that focuses on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its product, CardiolRx, is a pharmaceutically produced extra strength oral cannabidiol formulation that is entering a Phase II/III outcomes study in hospitalized patients testing positive for the COVID-19 virus.
Recommended Stories
- Five stocks we like better than Cardiol Therapeutics
- The Significance of Brokerage Rankings in Stock Selection
- FedEx Delivers Another Crushing Blow to Its Stock Price
- What is the Nikkei 225 index?
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- Bank Stocks – Best Bank Stocks to Invest In
- Micron Stock Will Retest All-Time Highs This Year
Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
